Clinical Trials on Ataxia Telangiectasia in United Kingdom
Total 266 results
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustCompletedAtaxia Telangiectasia (AT)United Kingdom
-
NHS TaysideUniversity of DundeeCompletedAtaxia-TelangiectasiaUnited Kingdom
-
University of PlymouthRecruitingAtaxia Telangiectasia | Ataxia Telangiectasia in ChildrenUnited Kingdom
-
University of NottinghamNottingham University Hospitals NHS Trust; Action for A-TCompleted
-
Matrix Biomed, Inc.The University of Texas Health Science Center, HoustonNot yet recruitingAtaxia Telangiectasia | Ataxia Telangiectasia Louis-Bar | Ataxia Telangiectasia in ChildrenUnited States
-
University of NottinghamNottingham University Hospitals NHS Trust; Royal Papworth HospitalActive, not recruitingAtaxia TelangiectasiaUnited Kingdom
-
Johns Hopkins UniversityTerminatedAtaxia-Telangiectasia (A-T)United States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Children's Hospital of PhiladelphiaCompletedAtaxia-TelangiectasiaUnited States
-
IntraBio IncRecruitingAtaxia Telangiectasia | Louis Bar SyndromeSpain, United States, Germany, United Kingdom
-
Quince Therapeutics S.p.A.BiotrialNot yet recruitingAtaxia TelangiectasiaBelgium, United States, Denmark, Germany, Italy, Norway, Poland, Spain, United Kingdom
-
Johns Hopkins UniversityCompleted
-
ErydelCompletedAtaxia TelangiectasiaItaly, United States, India, Israel
-
Quince Therapeutics S.p.A.CompletedGenetic Syndrome | Nervous System DiseaseIndia, United States, Australia, Germany, Italy, Norway, Poland, Spain, Tunisia, United Kingdom, Israel, Belgium
-
ErydelRecruitingAtaxia TelangiectasiaUnited States, Australia, Belgium, Germany, India, Italy, Poland, Spain, Tunisia
-
The Lowy Medical Research Institute LimitedActive, not recruitingMacular Telangiectasia Type 2United States, United Kingdom
-
The Lowy Medical Research Institute LimitedActive, not recruiting
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia (HHT)United Kingdom
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedIdiopathic Juxtafoveal TelangiectasiaUnited States
-
Neurotech PharmaceuticalsCompletedMacular TelangiectasiaUnited States, Australia
-
Imperial College LondonCompletedHereditary Haemorrhagic TelangiectasiaUnited Kingdom
-
Paul S. BernsteinCompletedIdiopathic Juxtafoveal TelangiectasiaUnited States
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
Manhattan Eye, Ear & Throat HospitalAlcon ResearchCompletedIdiopathic Perifoveal TelangiectasiaUnited States
-
National Eye Institute (NEI)CompletedMacular TelangiectasiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Radiation-Induced TelangiectasiasUnited States
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Imperial College LondonCompletedHereditary Haemorrhagic Telangiectasia (HHT)United Kingdom
-
Imperial College LondonBritish Heart FoundationActive, not recruitingTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Imperial College LondonCompletedTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Imperial College LondonWithdrawnTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Imperial College LondonBritish Heart FoundationRecruitingTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Imperial College LondonCompletedTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Imperial College LondonHammersmith Hospitals NHS TrustCompletedTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Johns Hopkins UniversityGenentech, Inc.Completed
-
University of FloridaAcorda TherapeuticsCompletedSpinocerebellar Ataxias Type 1 | Spinocerebellar Ataxias Type 2 | Spinocerebellar Ataxias Type 3 | Spinocerebellar Ataxias Type 6United States
-
Imperial College LondonThe Margaret Hayton HHT FundRecruitingTelangiectasia, Hereditary HemorrhagicUnited Kingdom
-
Ulthera, IncCompleted
-
National Eye Institute (NEI)CompletedTelangiectasiaUnited States
-
National Eye Institute (NEI)CompletedTelangiectasiaUnited States
-
Vaderis Therapeutics AGRecruitingHereditary Hemorrhagic Telangiectasia (HHT)United States, Spain, France, Belgium, Netherlands, Italy
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous MalformationsUnited Kingdom
-
Imperial College LondonTerminatedHereditary Haemorrhagic TelangiectasiaUnited Kingdom
-
University of California, Los AngelesCompleted
-
Mayo ClinicActive, not recruiting
-
University of PennsylvaniaCompletedHereditary Hemorrhagic Telangiectasia (HHT)United States
-
National Eye Institute (NEI)CompletedNeovascularizationUnited States
-
Hanny Al-Samkari, MDRecruitingHereditary Hemorrhagic TelangiectasiaUnited States